Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz (JAZZ) Lags on Q1 Earnings & Sales, Reaffirms '23 View
01:44pm, Thursday, 11'th May 2023
Jazz (JAZZ) reports dismal first-quarter results as earnings and sales miss expectations. The company reaffirms its financial guidance for 2023.
Jazz Pharmaceuticals PLC (JAZZ) Q1 2023 Earnings Call Transcript
08:49pm, Wednesday, 10'th May 2023
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Andrea Flynn - VP & Head, IR Bruce Cozadd - Co-Founder, Chairman & CEO Daniel Swis
Compared to Estimates, Jazz (JAZZ) Q1 Earnings: A Look at Key Metrics
08:31pm, Wednesday, 10'th May 2023
The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Why Shares of Avadel Soared This Week
03:44pm, Friday, 05'th May 2023
Avadel said it plans to launch its lead therapy to treat excessive daytime sleepiness in adults with narcolepsy, in early June. The company had no revenue in the first quarter.
Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting
07:45am, Wednesday, 19'th Apr 2023
Eleven abstracts emphasize Jazz's leadership in neuroscience and commitment to advance understanding of sleep disorders, epilepsy and movement disorders Three oral presentations share meaningful data
Top Pot Stocks For Long Term Investing? 3 To Watch In April
11:00am, Sunday, 09'th Apr 2023
Are Pot Stocks On Your List For April? The post Top Pot Stocks For Long Term Investing? 3 To Watch In April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Indus
Jazz (JAZZ) Up 0.4% Since Last Earnings Report: Can It Continue?
01:04pm, Friday, 31'st Mar 2023
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?
Finding The Long-Term Winners In The Cannabis Sector
01:16am, Monday, 27'th Mar 2023
This developing industry has ample opportunity and sustained tailwinds. Very few U.S. companies have positive operating margins; very few of their Canadian counterparts have positive gross margins.
My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years
06:45am, Tuesday, 21'st Mar 2023
Jazz Pharmaceuticals doesn't face many of the challenges other cannabis companies have to deal with. The company's current lineup and pipeline programs paint a bright picture for its future.
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
12:47pm, Thursday, 02'nd Mar 2023
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
Jazz Pharmaceuticals plc (JAZZ) Q4 2022 Earnings Call Transcript
09:12pm, Wednesday, 01'st Mar 2023
Jazz Pharmaceuticals plc (NASDAQ:JAZZ ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Darren Fox - Executive Director of Investor Relations Bruce Cozadd - Chairman and
Jazz Pharmaceuticals (JAZZ) Reports Q4 Loss, Misses Revenue Estimates
06:48pm, Wednesday, 01'st Mar 2023
Jazz (JAZZ) delivered earnings and revenue surprises of -113.73% and 0.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ)
09:48am, Tuesday, 28'th Feb 2023
Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Jazz (JAZZ) Could Beat Earnings Estimates Again
01:33pm, Friday, 24'th Feb 2023
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth
06:00am, Monday, 30'th Jan 2023
Their shares may be down, but their sales are up.
